Switzerland’s FDA equivalent, SwissMedic, has now fully approved Dr. Peter Oehen’s MAPS-sponsored MDMA/PTSD study. The protocol design had already been approved, and earlier this week we received …
MAPS received word from Dr. Peter Oehen, Principal Investigator of the Swiss MDMA/PTSD pilot study cosponsored by MAPS and the Swiss Association for Psycholytic Therapy, that the final written approval …
MAPS received word that the Israeli Ministry of Health has approved our MDMA/PTSD pilot study!! One condition was that the Israeli Anti-Drug Authority write a letter formally indicating support for the …
Dr.med. Peter Oehen submits an MDMA/PTSD protocol for review to a Swiss ethics committee, for a pilot study co-sponsored by MAPS and the Swiss Association for Psycholytic Therapy (SAePT). This study will …
The study protocol for the MDMA/PTSD study to take place in Israel was reviewed and approved by the Beer Yaakov Medical Center ethics committee (IRB). The study has now been sent to the Israeli national …
MAPS sponsored a very successful conference in Israel on research with MDMA, ibogaine and marijuana for the Israeli Ministry of Health, the Israeli Society of Addiction Medicine, and representatives from …
Rick Doblin met in Jerusalem with Dr. Miki Reiter, Israeli Ministry of Health, about MAPS’ proposed Israeli MDMA/PTSD pilot study in subjects with war and terrorism-related PTSD. Dr. Reiter is supportive …
An Israeli dentist who survived a suicide bombing in a Jerusalem cafe in March 2002 that killed about 11 people met in person with Rick Doblin in Jerusalem. The dentist contacted MAPS last week after searching …
Rick Doblin met in New York City with Israeli psychiatrist Dr. Moshe Kotler, the Principal Investigator of MAPS’ proposed Israeli MDMA/PTSD pilot study in subjects with war and terrorism- related …
On March 15, 2004, the lead investigator for MAPS’ concluded Spanish study of MDMA-assisted psychotherapy for PTSD, Jose Carlos Bouso, PhD, submitted this political analysis: Now that the progressive …
On March 12. 2004, Jose Carlos Bouso, PhD, participated in a televissd debate about drug policy. Here is his report: Neither the Director of the Spanish Antidrug Agency nor the Director of the Madrid Antidrug …
On March 4, 2004, the lead investigator for our Spanish study of MDMA-assisted psychotherapy for PTSD, Jose Carlos Bouso, PhD, was invited to participate in a Spanish TV program on March 12, 2004, along …
